Have a personal or library account? Click to login
Surgical Treatment of Patients with Adenocarcinoma of the Distal Esophageal Portion and Gastroesophageal Junction Performed After Neoadjuvant Chemotherapy and Combined Chemoradiation Cover

Surgical Treatment of Patients with Adenocarcinoma of the Distal Esophageal Portion and Gastroesophageal Junction Performed After Neoadjuvant Chemotherapy and Combined Chemoradiation

Open Access
|Apr 2022

References

  1. 1. Arnal MJD, Arenas ÁF, Arbeloa ÁL. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015;21(26):7933-7943.10.3748/wjg.v21.i26.7933449933726185366
  2. 2. Lou F, Sima CS, Adusumilli PS, et al. Esophageal Cancer Recurrence Patterns and Implications for Surveillance. J Thorac Oncol 2013;8(12):1558-1562.10.1097/01.JTO.0000437420.38972.fb406687524389438
  3. 3. Matsuda S, Takeuchi H, Kawakubo H, Kitagawa Y. Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis 2017;9:S731-40.10.21037/jtd.2017.03.171553899428815069
  4. 4. Kumagai K, Rouvelas I, Tsai JA, et al. Metaanalysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg 2014;101(4):321-38.10.1002/bjs.941824493117
  5. 5. Samalin E, Ychou M. Neoadjuvant therapy for gastroesophageal adenocarcinoma. World J Clin Oncol 2016;7(3):284-292.10.5306/wjco.v7.i3.284489689627298768
  6. 6. Qin Q, Xu H, Liu J, et al. Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A metaanalysis. Int J Surg 2018;59:11–18.10.1016/j.ijsu.2018.09.01330261331
  7. 7. Noordman BJ, Verdam MGE, Lagarde SM, et al. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial. Ann Oncol 2018;29:445-451.10.1093/annonc/mdx72629126244
  8. 8. Zhao X, Ren Y, Hu Y, et al. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials. PLOS ONE 2018;13(8):e0202185.10.1371/journal.pone.0202185610714530138325
  9. 9. Deng HY, Wang WP, Wang YC, et al. Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer. Eur J Cardiothorac Surg 2017;51(3):421-31.
  10. 10. Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(7):855-883.10.6004/jnccn.2019.003331319389
  11. 11. Ji KSY, Thomas SM, Roman SA, et al. Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer. J Gastrointest Surg 2019;23(5):885-894.10.1007/s11605-018-4007-330374818
DOI: https://doi.org/10.2478/amb-2022-0007 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 40 - 45
Submitted on: Dec 28, 2021
Accepted on: Jan 4, 2022
Published on: Apr 22, 2022
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 G. Yankov, M. Alexieva, M. Kovacheva-Slavova, B. Vladimirov, E. Mekov, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.